360 related articles for article (PubMed ID: 33425862)
1. Biomaterials in Valvular Heart Diseases.
Taghizadeh B; Ghavami L; Derakhshankhah H; Zangene E; Razmi M; Jaymand M; Zarrintaj P; Zarghami N; Jaafari MR; Moallem Shahri M; Moghaddasian A; Tayebi L; Izadi Z
Front Bioeng Biotechnol; 2020; 8():529244. PubMed ID: 33425862
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
3. Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction.
Zhang S; Liu C; Zhang Y; Wu Z; Feng K; Lai Y; Pei J; Guan T
Front Cardiovasc Med; 2023; 10():1135938. PubMed ID: 37273869
[TBL] [Abstract][Full Text] [Related]
4. Priorities for Patient-Centered Research in Valvular Heart Disease: A Report From the National Heart, Lung, and Blood Institute Working Group.
Lindman BR; Arnold SV; Bagur R; Clarke L; Coylewright M; Evans F; Hung J; Lauck SB; Peschin S; Sachdev V; Tate LM; Wasfy JH; Otto CM
J Am Heart Assoc; 2020 May; 9(9):e015975. PubMed ID: 32326818
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
7. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.
Chioncel O; Adamo M; Nikolaou M; Parissis J; Mebazaa A; Yilmaz MB; Hassager C; Moura B; Bauersachs J; Harjola VP; Antohi EL; Ben-Gal T; Collins SP; Iliescu VA; Abdelhamid M; Čelutkienė J; Adamopoulos S; Lund LH; Cicoira M; Masip J; Skouri H; Gustafsson F; Rakisheva A; Ahrens I; Mortara A; Janowska EA; Almaghraby A; Damman K; Miro O; Huber K; Ristic A; Hill L; Mullens W; Chieffo A; Bartunek J; Paolisso P; Bayes-Genis A; Anker SD; Price S; Filippatos G; Ruschitzka F; Seferovic P; Vidal-Perez R; Vahanian A; Metra M; McDonagh TA; Barbato E; Coats AJS; Rosano GMC
Eur J Heart Fail; 2023 Jul; 25(7):1025-1048. PubMed ID: 37312239
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of valvular heart disease.
Zeng YI; Sun R; Li X; Liu M; Chen S; Zhang P
Exp Ther Med; 2016 Apr; 11(4):1184-1188. PubMed ID: 27073420
[TBL] [Abstract][Full Text] [Related]
9. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
10. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
Coffey S; Cox B; Williams MJ
Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
[TBL] [Abstract][Full Text] [Related]
11. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
[TBL] [Abstract][Full Text] [Related]
12. Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
Bisson A; Bodin A; Clementy N; Bernard A; Babuty D; Lip GYH; Fauchier L
Int J Cardiol; 2018 Jun; 260():93-98. PubMed ID: 29540261
[TBL] [Abstract][Full Text] [Related]
13. Continuous-Flow Left Ventricular Assist Devices and Valvular Heart Disease: A Comprehensive Review.
Noly PE; Pagani FD; Noiseux N; Stulak JM; Khalpey Z; Carrier M; Maltais S
Can J Cardiol; 2020 Feb; 36(2):244-260. PubMed ID: 32036866
[TBL] [Abstract][Full Text] [Related]
14. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.
Liu FZ; Xue YM; Liao HT; Zhan XZ; Guo HM; Huang HL; Fang XH; Wei W; Rao F; Deng H; Liu Y; Lin WD; Wu SL
J Thorac Dis; 2014 Dec; 6(12):1724-30. PubMed ID: 25589965
[TBL] [Abstract][Full Text] [Related]
15. Non-cardiac surgery in patients with valvular heart disease.
Sorrentino R; Santoro C; Bardi L; Rigolin V; Gentile F
Heart; 2022 Jul; 108(15):1171-1178. PubMed ID: 34815334
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
[TBL] [Abstract][Full Text] [Related]
17. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.
Martinez C; Tsugu T; Sugimoto T; Lancellotti P
Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665
[TBL] [Abstract][Full Text] [Related]
19. Etiologies and Patterns of Valvular Heart Disease Among Cardiac Patients at the Cardiac Center of Ethiopia During February 2000 to April 2022.
Adere A; Bedru M; Afework M
Int J Gen Med; 2023; 16():2849-2856. PubMed ID: 37426520
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
